Clinical Trials Browser

Phase 1/2 × INDUSTRY × abivertinib × Clear all

NCT02330367 2021-09-10

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung